Tatsuya Mimura Selected Research

Retinal Vein Occlusion

1/2022	RELATIONSHIP BETWEEN CHOROIDAL FINDINGS AND GROWTH FACTORS, CYTOKINES, AND OTHER INFLAMMATORY MEDIATORS AFTER INTRAVITREAL RANIBIZUMAB INJECTION IN PATIENTS WITH MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSION.
12/2020	Retinal Microcirculation and Cytokines as Predictors for Recurrence of Macular Edema after Intravitreal Ranibizumab Injection in Branch Retinal Vein Occlusion.
6/2020	Relationship between retinal blood flow and cytokines in central retinal vein occlusion.
1/2017	Functional-morphological parameters, aqueous flare and cytokines in macular oedema with branch retinal vein occlusion after ranibizumab.
9/2016	POSSIBLE MOLECULAR BASIS OF BEVACIZUMAB THERAPY FOR MACULAR EDEMA IN BRANCH RETINAL VEIN OCCLUSION.
1/2016	Cytokines and Recurrence of Macular Edema after Intravitreal Ranibizumab in Patients with Branch Retinal Vein Occlusion.
1/2016	Cytokine Kinetics after Monthly Intravitreal Bevacizumab for Retinal Vein Occlusion Associated with Macular Oedema.
1/2016	Intravitreal Ranibizumab and Aqueous Humor Factors/Cytokines in Major and Macular Branch Retinal Vein Occlusion.
2/2015	Photopic negative response in branch retinal vein occlusion with macular edema.
1/2015	Role of soluble vascular endothelial growth factor receptor signaling and other factors or cytokines in central retinal vein occlusion with macular edema.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tatsuya Mimura Research Topics

Disease

58	Macular Edema 01/2022 - 01/2002
54	Retinal Vein Occlusion 01/2022 - 08/2005
16	Ischemia 05/2014 - 08/2005
15	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 01/2021 - 03/2004
13	Cataract (Cataracts) 01/2021 - 01/2002
8	Retinal Detachment (Retinal Detachments) 06/2013 - 09/2011
7	Retinal Perforations 05/2014 - 06/2011
7	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2014 - 08/2002
6	Inflammation (Inflammations) 01/2022 - 11/2006
4	Macular Degeneration (Age-Related Maculopathy) 01/2019 - 11/2013
4	Hypersensitivity (Allergy) 03/2015 - 03/2004
4	Glaucoma 01/2014 - 04/2010
4	Hypertension (High Blood Pressure) 01/2014 - 08/2002
4	Corneal Neovascularization 10/2011 - 11/2004
3	Low Tension Glaucoma 01/2014 - 05/2005
3	Dehydration (Water Stress) 07/2013 - 09/2004
3	Conjunctivitis 03/2011 - 10/2005
2	Wounds and Injuries (Trauma) 04/2019 - 01/2010
2	Diabetes Mellitus 04/2019 - 03/2012
2	Pruritus (Itching) 03/2015 - 12/2010
2	Rhinorrhea 03/2015 - 12/2010
2	Nasal Obstruction 03/2015 - 12/2010
2	Sneezing 03/2015 - 12/2010
2	Rhinitis 03/2015 - 12/2010
2	Hyperlipidemias (Hyperlipidemia) 01/2014 - 11/2011
2	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/2014 - 01/2014
2	Optic Neuritis (Retrobulbar Neuritis) 11/2013 - 11/2009
2	Obesity 11/2013 - 01/2003
2	Keratoconjunctivitis 01/2013 - 07/2011
2	Coma (Comas) 09/2011 - 09/2002
2	Corneal Edema 01/2011 - 02/2005
2	Keratoconus 05/2010 - 04/2010
2	Type 2 Diabetes Mellitus (MODY) 08/2009 - 01/2003
2	Edema (Dropsy) 11/2006 - 09/2004
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2005 - 06/2003
2	Vitreous Detachment (Posterior Vitreous Detachment) 09/2003 - 03/2003
1	Fibrosis (Cirrhosis) 01/2021
1	Atopic Dermatitis (Atopic Eczema) 01/2021
1	Hereditary Corneal Dystrophies 04/2019
1	Pterygium 01/2017
1	AIDS-Related Complex (ARC) 01/2016
1	Immune Complex Diseases (Immune Complex Disease) 08/2015
1	Exercise-Induced Allergies 03/2015
1	Asthma (Bronchial Asthma) 07/2014

Drug/Important Bio-Agent (IBA)

44	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2002
35	Retinaldehyde (Retinal)IBA 12/2020 - 09/2002
15	CytokinesIBA 01/2022 - 03/2003
15	Interleukin-6 (Interleukin 6)IBA 05/2014 - 01/2002
14	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 05/2014 - 05/2005
12	Fluorescein (Funduscein)FDA LinkGeneric 05/2014 - 01/2009
11	Immunoglobulin E (IgE)IBA 03/2015 - 03/2004
10	pigment epithelium-derived factorIBA 04/2013 - 02/2006
9	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2019 - 02/2013
7	AllergensIBA 08/2015 - 03/2004
7	EnzymesIBA 01/2014 - 01/2002
7	ImmunosorbentsIBA 01/2014 - 01/2002
7	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 12/2013 - 01/2012
6	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 10/2010
5	Ranibizumab (Lucentis)FDA Link 01/2022 - 01/2016
5	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 12/2013 - 06/2011
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2002
3	InterleukinsIBA 01/2019 - 01/2009
3	Monocyte Chemoattractant ProteinsIBA 01/2019 - 01/2014
3	Bevacizumab (Avastin)FDA Link 09/2016 - 01/2013
3	PTX3 proteinIBA 02/2014 - 02/2013
3	Immunoglobulins (Immunoglobulin)IBA 09/2013 - 03/2004
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2017 - 05/2005
2	Indicators and Reagents (Reagents)IBA 01/2017 - 09/2013
2	Sirtuin 1IBA 01/2016 - 11/2013
2	AntibodiesIBA 08/2015 - 09/2013
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 02/2014 - 02/2013
2	Synthetic Prostaglandins (Prostaglandin Analogues)IBA 01/2014 - 01/2014
2	Carbonic Anhydrase InhibitorsIBA 01/2014 - 01/2014
2	DecorinIBA 10/2011 - 01/2009
2	SteroidsIBA 12/2010 - 11/2006
2	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2009 - 08/2005
2	Dust (House Dust)FDA Link 09/2009 - 03/2004
2	CollagenIBA 11/2006 - 09/2004
2	3-hydroxycholest-7-ene-14-carbaldehydeIBA 11/2006 - 09/2004
2	DNA (Deoxyribonucleic Acid)IBA 10/2005 - 05/2002
1	SuspensionsIBA 01/2022
1	Endothelial Growth FactorsIBA 01/2022
1	Platelet-Derived Growth FactorIBA 09/2016
1	afliberceptIBA 04/2016
1	Immunoglobulin G (IgG)IBA 08/2015
1	Soaps (Soap)IBA 03/2015
1	Particulate MatterIBA 07/2014
1	LigandsIBA 06/2014
1	dorzolamide-timolol combination (Cosopt)FDA LinkGeneric 01/2014
1	Adenosine Triphosphate (ATP)IBA 01/2014

Therapy/Procedure

17	Vitrectomy 12/2013 - 08/2005
11	Therapeutics 01/2022 - 08/2005
7	Lasers (Laser) 01/2021 - 04/2010
6	Intravitreal Injections 09/2016 - 01/2012
5	Contact Lenses 04/2019 - 03/2005
5	Transplantation 07/2013 - 09/2004
3	Vitreoretinal Surgery 02/2014 - 06/2011
2	Hydrophilic Contact Lenses (Hydrophilic Contact Lens) 01/2021 - 01/2020
2	Activities of Daily Living (ADL) 03/2015 - 12/2010
2	Trabeculectomy (Trabeculoplasty) 09/2011 - 05/2005